|
⚲
|
| Keyboard |
| Christopher Haqq | |
|---|---|
| Firm | |
| Address | 451 D Street 5th Floor Boston, MA 02210 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Elicio Therapeutics Inc | 021-509031 | Executive Officer | 6.0 M of 6.0 M |
||
| Elicio Therapeutics Inc | 021-501744 | Executive Officer | 7.0 M of 7.0 M |
||
| TJB Medical Inc | 021-464630 | Executive Officer | 0.0 M of 0.5 M |
||
| Elicio Therapeutics Inc | 021-447361 | Executive Officer | 22.0 M of 50.0 M |
||
| Elicio Therapeutics Inc | 021-417559 | Executive Officer | 14.5 M of 15.0 M |
||
| Elicio Therapeutics Inc | 021-371058 | Executive Officer | 6.1 M of 30.0 M |
||
| Nina Biotherapeutics Inc | 021-209861 | Executive Officer | 0.9 M of 0.9 M |
||
| Pinta Biotherapeutics Inc | 021-209862 | Executive Officer | 6.3 M of 6.3 M |
||
| Santa Maria Biotherapeutics Inc | 021-209863 | Executive Officer | 6.3 M of 6.3 M |
||
| Nina Biotherapeutics Inc | 021-207719 | Executive Officer | 2.5 M of 2.5 M |
||
| Pinta Biotherapeutics Inc | 021-207720 | Executive Officer | 18.0 M of 18.0 M |
||
| Santa Maria Biotherapeutics Inc | 021-207721 | Executive Officer | 18.0 M of 18.0 M |
||